http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IL-173963-A0

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ae84948901b77f34fd51c41264d8d19c
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2603-28
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C251-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D451-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C251-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D451-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
filingDate 2006-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2006-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber IL-173963-A0
titleOfInvention Benzimidazolone and quinazolinone derivatives as agonists on human orl1 receptors
priorityDate 2003-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID18389
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID162542
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP79292
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100135588
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID29256
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP47748
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421360260
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4987
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35377
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP41146
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35370
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415858810
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID402851
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID344381

Total number of triples: 30.